Article Versions Notes

Tauzin A, Gendron-Lepage G, Nayrac M, Anand SP, Bourassa C, Medjahed H, Goyette G, Dubé M, Bazin R, Kaufmann DE, et al. Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection. Viruses. 2022; 14(3):532. https://doi.org/10.3390/v14030532

Tauzin, Alexandra, Gabrielle Gendron-Lepage, Manon Nayrac, Sai Priya Anand, Catherine Bourassa, Halima Medjahed, Guillaume Goyette, Mathieu Dubé, Renée Bazin, Daniel E. Kaufmann, and et al. 2022. "Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection" Viruses 14, no. 3: 532. https://doi.org/10.3390/v14030532

Tauzin, A., Gendron-Lepage, G., Nayrac, M., Anand, S. P., Bourassa, C., Medjahed, H., Goyette, G., Dubé, M., Bazin, R., Kaufmann, D. E., & Finzi, A. (2022). Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection. Viruses, 14(3), 532. https://doi.org/10.3390/v14030532